You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Etretinate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for etretinate and what is the scope of freedom to operate?

Etretinate is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for etretinate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 71
Clinical Trials: 3
Patent Applications: 5,706
DailyMed Link:etretinate at DailyMed
Recent Clinical Trials for etretinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
M.D. Anderson Cancer CenterPhase 2

See all etretinate clinical trials

Medical Subject Heading (MeSH) Categories for etretinate

US Patents and Regulatory Information for etretinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for etretinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986 ⤷  Sign Up ⤷  Sign Up
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986 ⤷  Sign Up ⤷  Sign Up
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986 ⤷  Sign Up ⤷  Sign Up
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.